All In Biotech

Free tool

FAERS Monitor: Tribenzor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 200175 or its brand name (Tribenzor, Amlodipine Besylate, Hydrochlorothiazide, Olmesartan Medoxomil). Reports on generic versions are filed under their own applications.

Reports

1,244

Serious

713

57% of reports

Hospitalization

452

Death reported

34

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • sprue-like enteropathy231
  • gastrooesophageal reflux disease141
  • acute kidney injury105
  • weight decreased105
  • diarrhoea104
  • dizziness104
  • constipation77
  • haemorrhoids76
  • chronic kidney disease72
  • nausea67
  • fatigue66
  • large intestine polyp60
  • drug ineffective57
  • headache54
  • hypotension53

Reports by year received

View as table
YearReports
20102
201131
201247
201372
201479
2015206
2016216
2017176
2018208
201992
202027
202115
202217
202313
202411
202512
202620

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,915 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sprue-like enteropathySignal231831.2737.4181,840
large intestine polypSignal60147.7115.38,526
haemorrhoidsSignal7666.153.24,795
gastrooesophageal reflux diseaseSignal14129.725.43,885
chronic kidney diseaseSignal7216.012.81,003
acute kidney injurySignal10511.69.71,014
weight decreasedSignal1056.45.3475
constipationSignal776.04.8317
hypotensionSignal534.53.4141
dizzinessSignal1043.52.9190
diarrhoeaSignal1042.72.3115
headache541.51.17
fatigue661.41.19
nausea671.41.19
drug ineffective570.70.66

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.